U.S. Markets for Cardiac Rhythm Management Products, February 2015
U.S. Markets for Cardiac Rhythm Management Products, February 2015
$4,750.00
Cardiac rhythm management (CRM) devices, which encompasses diagnostic and therapeutic systems, represents a well-established market that is still seeing innovation in some of the segments that compose it.
Publisher: Meddevicetracker
- Highlights
- Description
- Contents
This report will cover:
- procedure and market forecasts for the years 2014 to 2019;
- key factors influencing the growth of individual product markets;
- estimated market shares and sales among major U.S. suppliers;
- major supplier product portfolio analysis in individual product markets; and,
- innovative technology that could potentially change the way product markets develop.
Overview
Cardiac rhythm management (CRM) devices, which encompasses diagnostic and therapeutic systems, represents a well-established market that is still seeing innovation in some of the segments that compose it. Over the forecast period covered in this report, the estimated value of the U.S. market for CRM devices is expected to grow by approximately $1.1 billion at compound annual growth rate (CAGR) of 2.9%; of this holistic market, diagnostic CRM products are forecasted to grow at a CAGR of 4.8%, while therapeutic CRM products will grow at a CAGR of 2.7%.
Contents of this report include:
- procedure and market forecasts for the years 2014 to 2019;
- key factors influencing the growth of individual product markets;
- estimated market shares and sales among major U.S. suppliers;
- major supplier product portfolio analysis in individual product markets; and,
- innovative technology that could potentially change the way product markets develop.
The scope of the analysis of this report covers diagnostic and therapeutic modalities used in the management of cardiac rhythm disorders. Diagnostic modalities covered in this report include electrocardiography (ECG) systems and electrophysiology (EP) catheters. Therapeutic modalities discussed in this report include ablation catheters (surgical and transcatheter), cardiac resynchronization therapy (CRT) systems, external defibrillators, implantable cardioverter defibrillators (ICDs), and pacemakers.
TABLE OF CONTENTS
EXECUTIVE SUMMARY…………………………………………………………………………. ES-1
i. Methodology……………………………………………………………………….. ES-2
Exhibit ES-1: 2014, U.S. Cardiac Rhythm Management Market, Share by Products ………………………………………………………………………… ES-3
1. CARDIAC RHYTHM DISORDERS OVERVIEW…………………………………… 1-1
1.1 The Heart and Circulatory System ……………………………………………. 1-1
1.2 The Cardiac Conduction System………………………………………………. 1-6
1.3 Selected Cardiac Rhythm Disorders………………………………………….. 1-8
1.3.1 Bradycardia …………………………………………………………… 1-10
1.3.2 Sick Sinus Syndrome ……………………………………………… 1-12
1.3.3 Heart Block……………………………………………………………. 1-12
1.3.4 Tachycardia…………………………………………………………… 1-14
1.3.5 Atrial Fibrillation……………………………………………………… 1-15
1.3.6 Ventricular Fibrillation……………………………………………… 1-16
Exhibit 1-1: Cross-Section Diagrams of the Heart Illustrating the Direction of Blood Flow during Diastole and Systole ……………………………………………… 1-3
Exhibit 1-2: Cross-Section Diagrams of the Heart Valve Positions during Diastole and Systole……………………………………………………………………………. 1-5
Exhibit 1-3: Diagram of Selected Coronary Arteries ……………………………………… 1-7
Exhibit 1-4: Diagram of Cardiac Conduction System…………………………………….. 1-9
Exhibit 1-5: Cardiac Arrhythmias, Selected Statistics………………………………….. 1-11
2. U.S. MARKETS FOR CARDIAC RHYTHM MANAGEMENT DEVICES ….. 2-1
2.1 Diagnostic Cardiac Rhythm Management Devices, Market Analysis ……………………………………………………………………… 2-2
2.1.1 Electrocardiography Products, Market Analysis ……………. 2-2
2.1.1.1 Procedure Volumes………………………………….. 2-10
2.1.1.2 Products …………………………………………………. 2-11
2.1.1.3 Market Forecast ………………………………………. 2-11
2.1.1.4 Competitive Analysis ………………………………… 2-14
2.1.2 Electrophysiology Products, Market Analysis……………… 2-21
2.1.2.1 Procedure Volumes………………………………….. 2-24
2.1.2.2 Products …………………………………………………. 2-24
2.1.2.3 Market Forecast ………………………………………. 2-26
2.1.2.4 Competitive Analysis ………………………………… 2-27
2.2 Therapeutic Cardiac Rhythm Management Devices, Market Analysis ……………………………………………………………………. 2-30
2.2.1 Cardiac Resynchronization Therapy Products, Market Analysis ……………………………………………………… 2-32
2.2.1.1 Implantable Cardiac Pacing Systems………….. 2-32
2.2.1.2 Temporary Pacing Systems ………………………. 2-35
2.2.1.3 Procedure Volumes………………………………….. 2-35
2.2.1.4 Products …………………………………………………. 2-36
2.2.1.5 Market Forecast ………………………………………. 2-38
2.2.1.6 Competitive Analysis ………………………………… 2-39
2.2.2 External Defibrillator Products, Market Analysis………….. 2-42
2.2.2.1 Placement Volumes …………………………………. 2-44
2.2.2.2 Products …………………………………………………. 2-45
2.2.2.3 Market Forecast ………………………………………. 2-48
2.2.2.4 Competitive Analysis ………………………………… 2-49
2.2.3 Implantable Cardioverter Defibrillator Products, Market Analysis ……………………………………………………… 2-54
2.2.3.1 Procedure Volumes………………………………….. 2-56
2.2.3.2 Products …………………………………………………. 2-58
2.2.3.3 Market Forecast ………………………………………. 2-60
2.2.3.4 Competitive Analysis ………………………………… 2-62
2.2.4 Cardiac Resynchronization Therapy, Market Analysis ……………………………………………………… 2-63
2.2.4.1 Cardiac Resynchronization Therapy Systems …………………………………….. 2-65
2.2.4.1 Procedure Volumes………………………………….. 2-67
2.2.4.2 Products …………………………………………………. 2-69
2.2.4.3 Market Forecast ………………………………………. 2-69
2.2.4.4 Competitive Analysis ………………………………… 2-70
2.2.5 Arrhythmia Ablation ………………………………………………… 2-72
2.2.5.1 Transcatheter Arrhythmia Ablation……………… 2-74
2.2.5.2 Transcatheter Ablation of Atrial Fibrillation…… 2-76
2.2.5.3 Direct Energy-Based Surgical Ablation of Atrial Fibrillation……………………………………….. 2-77
2.2.5.4 Procedure Volumes………………………………….. 2-79
2.2.5.5 Products …………………………………………………. 2-80
2.2.5.6 Market Forecast ………………………………………. 2-80
2.2.5.7 Competitive Analysis ………………………………… 2-83
Exhibit 2-1: Cardiac Rhythm Management, Combined Procedure Volumes Forecast, 2014-2019 ………………………………………………………………. 2-3
Exhibit 2-2: Cardiac Rhythm Management Products, Combined Market Forecast, 2014-2019 ………………………………………………………………. 2-5
Exhibit 2-3: Normal Electrocardiogram Tracing……………………………………………. 2-8
Exhibit 2-4: Electrocardiography, Procedure Volumes Forecast, 2014-2019 ….. 2-12
Exhibit 2-5: Electrocardiography Products, Market Forecast, 2014-2019……….. 2-15
Exhibit 2-6: 2014, Electrocardiography Products Market, Share by Supplier ….. 2-22
Exhibit 2-7: Diagnostic Electrophysiology, Procedure Volumes Forecast, 2014-2019 ……………………………………………………………….. 25
Exhibit 2-8: Electrophysiology Systems, Market Forecast, 2014-2019…………… 2-28
Exhibit 2-9: 2014, Electrophysiology Products Market, Share by Supplier……… 2-31
Exhibit 2-10: NBG Code for Implantable Pacemaker Systems………………………. 2-34
Exhibit 2-11: Cardiac Pacemaker Implantation, Procedure Volumes Forecast, 2014-2019 …………………………………………………………….. 2-37
Exhibit 2-12: Pacemaker Products, Market Forecast, 2014-2019 …………………… 2-40
Exhibit 2-13: 2014, Pacemaker Products Market, Share by Supplier………………. 2-43
Exhibit 2-14: External Defibrillation, Placement Volumes Forecast, 2014-2019 …………………………………………………………….. 2-46
Exhibit 2-15: External Defibrillator Products, Market Forecast, 2014-2019 ………. 2-50
Exhibit 2-16: 2014, External Defibrillator Products Market, Share by Supplier ………………………………………………………………………….. 2-53
Exhibit 2-17: NBD Code and Labeling for Implantable Cardioverter Defibrillators………………………………………………………. 2-57
Exhibit 2-18: Implantable Cardioverter Defibrillator Implantation, Procedure Volumes Forecast, 2014-2019 ……………………………………………….. 2-59
Exhibit 2-19: Implantable Cardioverter Defibrillator Products, Market Forecast, 2014-2019 …………………………………………………………….. 2-61
Exhibit 2-20: 2014, Implantable Cardioverter Defibrillator Products Market, Share by Supplier ………………………………………………………………………….. 2-64
Exhibit 2-21: Cardiac Resynchronization Therapy, Procedure Volumes Forecast, 2014-2019 …………………………………………………………….. 2-68
Exhibit 2-22: Cardiac Resynchronization Therapy Products, Market Forecast, 2014-2019 …………………………………………………………….. 2-71
Exhibit 2-23: 2014, Cardiac Resynchronization Therapy Products Market, Share by Supplier ………………………………………………………………………….. 2-73
Exhibit 2-24: Cardiac Ablation, Procedure Volumes Forecast, 2014-2019……….. 2-81
Exhibit 2-25: Cardiac Ablation Products, Market Forecast, 2014-2019 …………… 2-84
Exhibit 2-26: 2014, Transcatheter Ablation Systems Products Market, Share by Supplier ………………………………………………………………………….. 2-87
Exhibit 2-27: 2014, Surgical Ablation Systems Products Market, Share by Supplier ………………………………………………………………………….. 2-90
APPENDIX: COMPANY LISTING……………………………………………………………… A-1
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Neuromodulation KOL Interview 
Sign up to the